Skip to main content
. 2013 Dec 19;8(12):e84806. doi: 10.1371/journal.pone.0084806

Figure 1. BDNF levels are decreased following acute BZ treatment.

Figure 1

(A) Representative immunoblots for c-Fos, BDNF, and GAPDH, as well as Coomassie gel representing the loading control for VEH, ZP, or TZ-treated HIP; (B) There is no change in c-Fos protein levels following BZ treatment as measured by western blots (n= 3). (C) There is a significant decrease in BDNF levels in the HIP following ZP and TZ treatment as measured by western blots (n= 4); (D) There is a significant decrease in BDNF levels following BZ treatment as measured by ELISA (n= 3-6). * p< 0.05; IDV: integrated density values.

HHS Vulnerability Disclosure